Correction: In vivo Evaluation of Anti-Hyperglycemic, Anti-hyperlipidemic and Anti-Oxidant Status of Liver and Kidney of Thymol in STZ-Induced Diabetic Rats

Please copy the URL and add it into your RSS Feed Reader.

Drug Res (Stuttg) 2019; 69(01): e3
DOI: 10.1055/a-0692-2171

Erratum

Authors

Bijan Ghorbanpour Oskouei

¹Food and Drug Affairs, Tabriz University of Medical Science, Tabriz, Iran

²Student Research Committee, Tabriz University of Medical Science, Tabriz, Iran
Soheil Abbaspour-Ravasjani

³Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
Seyed Jamal Musavinejad

⁴Islamic Azad University, Tabriz Branch, Faculty of Veterinary Medicine, Tabriz, Iran
Seyed Ahmad Salehzadeh

⁵Department of Medicinal Biotechnology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran
Alireza Abdolhosseinzadeh

⁶Young Researchers and Elite Club, Bonab Branch, Islamic Azad university, Bonab, Iran
Hamed Hamishehkar

⁷Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
Kazem Ghahremanzadeh

⁸Department of Pathology, Tabriz University of Medical Sciences, Tabriz, Iran
Behrooz Shokouhi

⁸Department of Pathology, Tabriz University of Medical Sciences, Tabriz, Iran

In vivo Evaluation of Anti-Hyperglycemic, Anti-hyperlipidemic and Anti-Oxidant Status of Liver and Kidney of Thymol in STZ-Induced Diabetic Rats

Bijan Ghorbanpour Oskouei, Soheil Abbaspour-Ravasjani, Seyed Jamal Musavinejad et al.

Drug Res 2018, DOI: 10.1055/a-0646-3803

The institute affiliations of Soheil Abbaspour-Ravasjani and Hamed Hamishehkar has been corrected.

Article published online:
24 August 2018